FDA Alerts Public to Leakage Risk in Abiomed Impella Heart Pump Kits
The FDA has issued an early alert regarding a significant leakage risk with Abiomed's Impella heart pump introducer kits. Manufacturing defects can cause unexpected leakage, increasing the potential for access-site bleeding. Eight major bleeding incidents and three contested patient deaths have been associated with this issue.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.